Update on Edoxaban for the Prevention and Treatment of Thromboembolism: Clinical Applications Based on Current Evidence

Advances in Hematology
Ali Zalpour, Thein Hlaing Oo

Abstract

Vitamin K antagonists (VKA) and heparins have been utilized for the prevention and treatment of thromboembolism (arterial and venous) for decades. Targeting and inhibiting specific coagulation factors have led to new discoveries in the pharmacotherapy of thromboembolism management. These targeted anticoagulants are known as direct oral anticoagulants (DOACs). Two pharmacologically distinct classes of targeted agents are dabigatran etexilate (Direct Thrombin Inhibitor (DTI)) and rivaroxaban, apixaban, and edoxaban (direct oral factor Xa inhibitors (OFXaIs)). Emerging evidence from the clinical trials has shown that DOACs are noninferior to VKA or low-molecular-weight heparins in the prevention and treatment of thromboembolism. This review examines the role of edoxaban, a recently approved OFXaI, in the prevention and treatment of thromboembolism based on the available published literature. The management of edoxaban in the perioperative setting, reversibility in bleeding cases, its role in cancer patients, the relevance of drug-drug interactions, patient satisfaction, financial impacts, and patient education will be discussed.

References

Aug 1, 1973·The British Journal of Surgery·R N PughR Williams
Jul 23, 2003·Journal of Thrombosis and Haemostasis : JTH·K G MannS Butenas
Aug 4, 2004·Circulation·Alain LeizoroviczUNKNOWN PREVENT Medical Thromboprophylaxis Study Group
Jun 9, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Nigel MackmanNigel S Key
Aug 1, 2007·Circulation·Jack HirshJohn W Eikelboom
Oct 6, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·David Gailani, Thomas Renné
Mar 22, 2008·British Journal of Haematology·Douglas Wardrop, David Keeling
Sep 4, 2008·Thrombosis and Haemostasis·Javier Trujillo-SantosUNKNOWN RIETE Registry
Feb 19, 2009·Anaesthesia·J A J MartynL I Eriksson
Apr 25, 2009·Cancer Investigation·Ted Wun, Richard H White
Apr 2, 2010·American Journal of Preventive Medicine·Michele G BeckmanThomas L Ortel
Aug 24, 2010·Advances in Chronic Kidney Disease·William E Dager, Tyree H Kiser
Dec 7, 2010·The New England Journal of Medicine·Rupert BauersachsSebastian Schellong
Dec 18, 2010·Nature Reviews. Drug Discovery·Elisabeth PerzbornFrank Misselwitz
Feb 15, 2011·Journal of Thrombosis and Thrombolysis·Pancras C WongDonglu Zhang
Mar 2, 2011·Journal of Thrombosis and Thrombolysis·Edith NutescuErika Hellenbart
Mar 26, 2011·Chest·Alex C SpyropoulosUNKNOWN IMPROVE Investigators
May 7, 2011·British Journal of Clinical Pharmacology·Vincenzo Toschi, Maddalena Lettino
Jul 14, 2011·Nature Reviews. Cardiology·Omair Yousuf, Deepak L Bhatt
Jul 26, 2011·The New England Journal of Medicine·John H AlexanderUNKNOWN APPRAISE-2 Investigators
Nov 15, 2011·The New England Journal of Medicine·Samuel Z GoldhaberUNKNOWN ADOPT Trial Investigators
Nov 15, 2011·The New England Journal of Medicine·Jessica L MegaUNKNOWN ATLAS ACS 2–TIMI 51 Investigators
Mar 14, 2012·Journal of Thrombosis and Haemostasis : JTH·M N LevineJ Julian
Mar 28, 2012·The New England Journal of Medicine·Harry R BüllerAnnelise Segers
Apr 5, 2012·American Journal of Hematology·Scott KaatzJack Ansell
Aug 31, 2012·Blood·Alex C Spyropoulos, James D Douketis
Sep 1, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Mohinder S BathalaJeanne Mendell
Sep 28, 2012·Thrombosis and Haemostasis·Shashank RohatagiDaniel E Salazar
Oct 2, 2012·Circulation Research·Calvin H YehJeffrey I Weitz
Dec 12, 2012·The New England Journal of Medicine·Giancarlo AgnelliUNKNOWN AMPLIFY-EXT Investigators
Jan 8, 2013·Clinical Pharmacokinetics·Francesco Scaglione
Feb 8, 2013·The New England Journal of Medicine·Alexander T CohenUNKNOWN MAGELLAN Investigators

❮ Previous
Next ❯

Citations

Oct 19, 2016·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Jean AmiralJerard Seghatchian
Oct 26, 2016·Texas Heart Institute Journal·Joanna Esther Molina RazaviMehdi Razavi
Jul 25, 2018·European Heart Journal. Acute Cardiovascular Care·Thomas A ZelnikerRobert P Giugliano
Dec 23, 2016·Health Services Insights·Tagore SunkaraMadhavi Reddy

❮ Previous
Next ❯

Methods Mentioned

BETA
total hip arthroplasty
coronary artery bypass
biopsy

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

European Journal of Internal Medicine
Massimo Franchini, Pier Mannuccio Mannucci
Best Practice & Research. Clinical Haematology
Daniel J Quinlan, Bengt I Eriksson
© 2021 Meta ULC. All rights reserved